Summary The utility of the polymerase chain reaction (PCR) as a technique for determining the expression of transforming growth factor ,B (TGF-fl) and of the oestrogen receptor (ER) in clinical breast cancer tissue was examined. PCR analysis was compared with immunocytochemical assays for TGF-,B and for ER. Seventy confirmed breast carcinoma samples were analysed for ER using both techniques with a statistically highly significant concordance (P<0.001) between the two methods. Nineteen samples were observed to be ER positive and 46 samples were found to be ER negative by both techniques. Forty-eight samples were analysed for TGF-,B using both PCR and immunocytochemistry. Of the 24 samples observed to be positive for TGF-,B by immunocytochemistry, all were found to be positive for TGF-,B mRNA (PCR). Similarly, the 24 samples observed to be TGF-,B negative by immunocytochemistry were also negative for TGF-fl mRNA, indicating 100% specificity and 100% sensitivity of the PCR technique. PCR is therefore considered a viable technique for analysis of both ER and TGF-,B in small samples such as fine-needle aspirates.